Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.570
+0.040 (1.13%)
At close: Sep 12, 2025, 4:00 PM EDT
3.500
-0.070 (-1.96%)
After-hours: Sep 12, 2025, 7:29 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $612.51 million as of September 12, 2025. Its market cap has increased by 253.31% in one year.
Market Cap
612.51M
Enterprise Value
521.47M
1-Year Change
253.31%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $612.51M, an increase of 40.70%. That is a compound annual growth rate of 7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 612.51M | 207.02% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |